Source: Virtual Congress 2020 – Clinical data and COPD management
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. T. Rodrigues (Lisboa, Portugal), M. Romão (Lisboa, Portugal), R. Pereira (Lisboa, Portugal), H. Peter (Lisboa, Portugal), A. Marques (Lisboa, Portugal), L. Rocha (Lisboa, Portugal), J. Cardoso (Lisboa, Portugal), J. Alves (Lisboa, Portugal). Using pharmacy sales data to estimate treated COPD prevalence in Portugal. 998

Member's Comments

No comment yet.

Related content which might interest you: The drug costs associated with COPD prescription medicine in Denmark Source: Annual Congress 2012 - Looking at the cost effectiveness of asthma and COPD treatment by novel drugs and improved management Year: 2012 COPD prevalence data derived from a health screening clinic – less bias than expected Source: Eur Respir J 2006; 28: Suppl. 50, 741s Year: 2006 A comparison of the management of COPD exacerbations in six European hospitals: demographics and baseline data Source: Annual Congress 2008 - Management of COPD Year: 2008 Changes in asthma drug use in France between 2006 and 2015: a claims data study Source: International Congress 2018 – Epidemiology of asthma, COPD and factors that associate with lung function Year: 2018 General practice recording of COPD prevalence, severity and management in a former coal mining community in the UK Source: Eur Respir J 2007; 30: Suppl. 51, 128s Year: 2007 Cost of asthma in patients treated with national asthma guideline in Turkey Source: Eur Respir J 2003; 22: Suppl. 45, 481s Year: 2003 Medication use and disease control of asthma patients in Flanders: a cross-sectional community pharmacy study Source: Eur Respir J 2005; 26: Suppl. 49, 47s Year: 2005 A real world experience of COPD exacerbations and possible association with Bronchiectasis in a medium size teaching hospital in the northwest of England Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies? Year: 2017 Validity and interpretation of mortality, health service and survey data on COPD and asthma in England Source: Eur Respir J 2003; 21: 279-286 Year: 2003 Somerset community COPD service established to reduce admissions Source: Annual Congress 2009 - COPD case-finding and management in primary care Year: 2009 The prevalence of asthma and COPD in Italy: A practice-based study Source: Annual Congress 2010 - Prevalence and incidence of asthma and COPD Year: 2010 Economic burden of asthma among patients visiting a private hospital in south India Source: International Congress 2017 – Does economisation of medicine transfer into benefits for patients? Year: 2017 COPD treatment defaulters in tertiary care hospital in suburban India: Reasons for treatment interruptions, its prevalence and predictors Source: Annual Congress 2013 –COPD drugs: new findings Year: 2013 Persistence to COPD therapies and impact on exacerbations: a French claims data study Source: International Congress 2018 – Respiratory epidemiology: from COPD to factors that associate with lung function and infections Year: 2018 A cross-sectional study on the use of information technology among people with COPD, in Sweden Source: Virtual Congress 2021 – Respiratory physiotherapy: e-health, activities of daily living and measurement properties of instruments Year: 2021 Trends of asthma in Mexico. A 10 years analysis in a nationwide health institution Source: Eur Respir J 2002; 20: Suppl. 38, 317s Year: 2002 Ozone effects on daily number of emergency visits for COPD and asthma at hospitals in Stockholm, Sweden Source: Eur Respir J 2004; 24: Suppl. 48, 607s Year: 2004 The cost burden of COPD in France: A retrospective analysis of an administrative primary care database Source: International Congress 2017 – Does economisation of medicine transfer into benefits for patients? Year: 2017